Skip to main content
Caplight Logo









Synapse Biomedical Inc.

Synapse Biomedical Inc.

Private
Oberlin, OhioHealthcare & Life Scienceshttps://synapsebiomedical.com/

Last Round

Debt

Dec 18, 2013

Total Funding Raised

$3.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Synapse Biomedical Inc. is a medical device company that specializes in the research, development, and commercialization of neurostimulation products, including the NeuRx Diaphragm Pacing System for patients with respiratory insufficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurostimulationdiaphragm pacingmedical devicerespiratory supportimplantable deviceventilator weaningneuromodulationmechanical ventilationrespiratory insufficiencymedtechbionicsbioelectronic medicineALS treatmentspinal cord injury

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synapse Biomedical Inc. Comparables

Compare Synapse Biomedical Inc. with similar companies based on industry and business-model similarity.

Synapse Biomedical Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avery Biomedical Devices, Inc.
93%
Lungpacer Medical
89%
Liberate Medical
83%

Synapse Biomedical Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 18, 2013
Series C ExtensionJan 21, 2010
VC RoundNov 1, 2005

Key People

Founding team and executive leadership

Mous Diop

Chief Operating Officer & EU Managing Director & Board of Directors, Secretary

Executive Team

Synapse Biomedical Inc. Investors

Notable investors and investment history

Synapse Biomedical Inc. investors
InvestorRounds
Ohio Third Frontier CommissionDebt
JumpStartVC Round
Palo Alto InvestorsVC Round
Vivo CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 60% MoM, reaching 3.7K.

  • Jun 19, 2026

    Monthly visitors increased 41% MoM, reaching 2.3K.

Synapse Biomedical Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synapse Biomedical Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synapse Biomedical Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOberlin, Ohio
Employee Range33
Year Founded2002
Last FundingDec 18, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?